Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Adaptive Pathways and Patient Access: Pushing Payer Boundaries or Facilitating New Payment Models? The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.
The issue panel was moderated by Jacoline Bouvy, PhD, Scientific Adviser, National Institute for Health and Care Excellence, London, UK. Speakers for the session included:
- Hans-Georg Eichler, MD, MSc, Senior Medical Officer, European Medicine Agency, London, UK
- Ad Schuurman, MSc, MBA, President of MEDEV, Zorginstituut Nederland, Diemen, The Netherlands
- Claudine Sapede, PharmD, MSc, Global HTA and Payment Policy Lead, F. Hoffmann-La Roche Ltd, Basel, Switzerland
This panel explored the use of adaptive pathways in the development medicines. Speakers noted that adaptive pathways could help patients gain earlier access to promising treatments in areas of high unmet medical needs, but acknowledged that this approach may also have implications for access decisions at the national and regional levels that need to be explored.
Jacoline Bouvy, PhD provided an overview of ADAPT SMART, the enabling platform for the coordination of Medicines Adaptive Pathways for Patients (MAPPs) activities. MAPPS seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in the product lifespan in a sustainable fashion. Hans-Georg Eichler, MD, MSc discussed the regulatory viewpoint on adaptive pathways, and Ad Schuurman, MSc, MBA and Claudine Sapede, PharmD, MSc provided perspectives from the payer and industry sectors, respectively.
Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.